# A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

> **NCT04092595** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PF-06651600
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT04092595
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-26
- **Primary completion:** 2020-01-15
- **Final completion:** 2020-01-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04092595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04092595, "A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04092595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*